Alcon AG | ALC - Assets

Stock Price
50.42
Daily Change
0.81 1.63%
Monthly
-21.10%
Yearly
-31.94%
Q2 Forecast
49.42

Alcon AG reported $31.62B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AstraZeneca USD 114.02B 59M Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Essilor EUR 63.9B 1.97B Dec/2025
Fresenius EUR 41.4B 1.07B Dec/2025
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Philips EUR 27.27B 322M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
Smith & Nephew USD 10.69B 150M Dec/2025
Sonova Holding CHF 5.92B 468.2M Jun/2025
UCB EUR 18.16B 971M Dec/2025